Undifferentiated Sarcoma
📧 Sign up to get email alerts when something new happens for Undifferentiated Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Lurbinectedin in FET-Fused Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluates Lurbinectedin in FET-fused tumors such as Ewing sarcoma and desmoplastic small round cell tumor. Recruitment is on…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Nivolumab in Selected Uterine Cancer Patients [Phase 2]
Phase 2 study of Nivolumab in selected uterine cancers has completed enrollment and posted results in 2024.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children [Phase 1]
A Phase 1 clinical trial of doxorubicin with hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative brachytherapy for unresect…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
This clinical trial update reports on biomarker differences observed in samples from patients with undifferentiated sarcomas, a subset of so…